ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.61
-0.26 (-1.01%)
At close: Aug 3, 2026, 4:00 PM EDT
25.29
-0.32 (-1.25%)
After-hours: Aug 3, 2026, 7:34 PM EDT
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, ACADIA Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $32.95. The average 1-year stock price forecast is 28.66% higher than the current stock price, while the lowest is $17 (-33.62%) and the highest is $45 (+75.71%).
Price Target: $32.95 (+28.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 21 | 21 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $27 → $37 | Buy | Maintains | $27 → $37 | +44.47% | Jul 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | -2.38% | Jul 25, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $34 → $36 | Buy | Reiterates | $34 → $36 | +40.57% | Jul 21, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +36.67% | Jul 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $30 | Buy | Reiterates | $30 | +17.14% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
1.24B
from 1.07B
Increased by 15.86%
Revenue Next Year
1.40B
from 1.24B
Increased by 12.82%
EPS This Year
0.37
from 0.83
Decreased by -55.81%
EPS Next Year
0.85
from 0.37
Increased by 133.06%
EPS and Forward PE are based on non-GAAP adjusted numbers.